|
|
|
|
| LEADER |
02875nam a22003975i 4500 |
| 001 |
978-3-642-76910-8 |
| 005 |
20191028041149.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1991 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642769108
|
| 024 |
7 |
|
|a 10.1007/978-3-642-76910-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Prostaglandin E1
|b New Aspects on Pharmacology, Metabolism and Clinical Efficacy /
|c edited by Curt Diehm, Helmut Sinzinger, Waltraud Rogatti.
|
| 250 |
|
|
|a 1st ed. 1991.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 1991.
|
| 300 |
|
|
|a XI, 117 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Cellular Sites of Action of Prostaglandins in the Cardiovascular System -- On the Metabolism and Pharmacokinetics of Prostaglandin E1 Administered by Intra-arterial or Intravenous Infusions -- Actions of PGE1 PGE0 and 15-keto-PGE1 on Vessel Tone In Vitro -- 13,14-dihydro-PGE1 (PGE0) but not 15-keto-PGE1 is a Potent Inhibitor of Human Platelet and Neutrophil Activation -- Comparable Inhibitory Action of PGE1 and 13–14-dihydro-PGE1 on Smooth Muscle Cell Activity and Extracellular Matrix Production -- PGE1 and 13,14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism -- Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease -- A Comparison of Different Dosages of Intra-arterial and Intravenous Administered Prostaglandin E1 in Healthy Volunteers -- Transcutaneous Oxygen Pressure at Different Dosages of Intravenous Prostaglandin E1 in Patients with Severe Arterial Occlusive Disease: A Double-Blind, Placebo-Controlled Study -- Transcutaneous PO2 During Intra-arterial and Intravenous PGE1 Infusion in Patients with Critical Limb Ischaemia -- Effects of Intravenous PGE1 on Blood Flow and Microcirculation: A Double-Blind, Placebo-Controlled Study in Patients with Critical Limb Ischaemia -- Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication -- Adjuvant Intravenous PGE1 Treatment After Profundaplasty for Limb Salvage.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Metabolic diseases.
|
| 650 |
|
0 |
|a Allergy.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Cardiology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Metabolic Diseases.
|
| 650 |
2 |
4 |
|a Allergology.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Cardiology.
|
| 700 |
1 |
|
|a Diehm, Curt.
|e editor.
|
| 700 |
1 |
|
|a Sinzinger, Helmut.
|e editor.
|
| 700 |
1 |
|
|a Rogatti, Waltraud.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-76910-8
|